GOG - 0238 (Pelvic-only recurrence of carcinoma of the uterine corpus)


Study Description: The main purpose of this study is to compare radiation therapy in combination with weekly treatment with the chemotherapy drug cisplatin to the standard treatment for this type of cancer. The standard treatment for patients with your type of cancer is radiation therapy alone. Radiation therapy is a cancer treatment that uses radiation beams from outside your body, or radioactive seeds or pellets placed directly into the tissue to kill cancer cells. Radiation therapy alone has not been very effective in treating large tumors that recur (come back) in the pelvis, lymph nodes or vagina. Radiation therapy in combination with weekly treatment with the chemotherapy drug cisplatin has been found to be very effective in treating patients with advanced cervical cancers. Another purpose of the study is to evaluate the side effects of the combination of radiation therapy and cisplatin.

Contact for Enrollment

    
     (706) 721-2505
    keadams@augusta.edu

    Submit Information Online

Principal Investigator: Sharad Ghamande

Eligibility Criteria: Eligible Patients: Patients with recurrent endometrial cancer. Ineligible Patients: Patients with evidence of disease outside of the pelvis Please visit clinicaltrials.gov for a complete list of inclusion and exclusion criteria.

Compensation: No, subjects will not be compensated.

 

Didn't find a study to participate in?

If you don't see specific studies that interest you, please submit your contact information for future studies.